MXPA03001556A - Derivados de bifenilo. - Google Patents

Derivados de bifenilo.

Info

Publication number
MXPA03001556A
MXPA03001556A MXPA03001556A MXPA03001556A MXPA03001556A MX PA03001556 A MXPA03001556 A MX PA03001556A MX PA03001556 A MXPA03001556 A MX PA03001556A MX PA03001556 A MXPA03001556 A MX PA03001556A MX PA03001556 A MXPA03001556 A MX PA03001556A
Authority
MX
Mexico
Prior art keywords
biphenyl derivatives
integrin inhibitors
integrin
inhibitors
biphenyl
Prior art date
Application number
MXPA03001556A
Other languages
English (en)
Inventor
Simon Goodman
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of MXPA03001556A publication Critical patent/MXPA03001556A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
MXPA03001556A 2000-08-23 2001-07-24 Derivados de bifenilo. MXPA03001556A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10041428A DE10041428A1 (de) 2000-08-23 2000-08-23 Biphenylderivate
PCT/EP2001/008514 WO2002016323A1 (de) 2000-08-23 2001-07-24 Biphenylderivate und ihre verwendung als intigrininhibitoren

Publications (1)

Publication Number Publication Date
MXPA03001556A true MXPA03001556A (es) 2003-06-06

Family

ID=7653542

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03001556A MXPA03001556A (es) 2000-08-23 2001-07-24 Derivados de bifenilo.

Country Status (17)

Country Link
US (1) US20030187289A1 (es)
EP (1) EP1311484A1 (es)
JP (1) JP2004506717A (es)
KR (1) KR20030022419A (es)
CN (1) CN1447795A (es)
AU (1) AU8973201A (es)
BR (1) BR0113373A (es)
CA (1) CA2420205A1 (es)
CZ (1) CZ2003670A3 (es)
DE (1) DE10041428A1 (es)
HU (1) HUP0302822A3 (es)
MX (1) MXPA03001556A (es)
NO (1) NO20030812L (es)
PL (1) PL359154A1 (es)
SK (1) SK2952003A3 (es)
WO (1) WO2002016323A1 (es)
ZA (1) ZA200302253B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10127041A1 (de) * 2001-06-02 2002-12-05 Merck Patent Gmbh Integrinantagonisten
US20190242908A1 (en) 2016-09-08 2019-08-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for diagnosing and treating nephrotic syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034164B1 (en) * 1997-11-24 2004-05-19 Merck & Co., Inc. Substituted beta-alanine derivatives as cell adhesion inhibitors
WO1999052879A1 (en) * 1998-04-14 1999-10-21 American Home Products Corporation Acylresorcinol derivatives as selective vitronectin receptor inhibitors
EP0960882A1 (en) * 1998-05-19 1999-12-01 Hoechst Marion Roussel Deutschland GmbH Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists

Also Published As

Publication number Publication date
WO2002016323A1 (de) 2002-02-28
DE10041428A1 (de) 2002-03-07
SK2952003A3 (en) 2003-06-03
HUP0302822A2 (hu) 2003-12-29
KR20030022419A (ko) 2003-03-15
NO20030812D0 (no) 2003-02-21
US20030187289A1 (en) 2003-10-02
ZA200302253B (en) 2004-06-28
HUP0302822A3 (en) 2004-07-28
CZ2003670A3 (cs) 2003-06-18
CA2420205A1 (en) 2003-02-21
PL359154A1 (en) 2004-08-23
EP1311484A1 (de) 2003-05-21
CN1447795A (zh) 2003-10-08
BR0113373A (pt) 2003-07-15
NO20030812L (no) 2003-02-21
AU8973201A (en) 2002-03-04
JP2004506717A (ja) 2004-03-04

Similar Documents

Publication Publication Date Title
ZA200205557B (en) 4-Aminopicolinates and their use as herbicides.
HRP20020375A2 (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
ZA200300667B (en) Biphenyl derivatives and their use as PPAR-gamma receptor activators.
AU8729901A (en) Benzoylpyrazols and their use as herbicides
MXPA03005298A (es) Inhibidores de girasa y usos de los mismos.
HK1047743A1 (en) New use and novel n-azabicyclo-amide derivatives.
ZA200210411B (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals.
MXPA03004593A (es) Derivados de naftaleno.
ZA200210180B (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals.
MXPA03004932A (es) 2-anilino-bencimidazoles sustituidos y su uso como inhibidores de nhe.
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
ZA200207489B (en) Apomorphine derivatives and methods for their use.
MXPA03001557A (es) Derivados bifenilo.
HK1057900A1 (en) 2-Aminothiazoline derivatives and their use as no-synthase inhibitors.
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
MXPA03001556A (es) Derivados de bifenilo.
AU7815201A (en) Synthetic salicylihalamides, apicularens and derivatives thereof
AU2001289732A1 (en) Biphenyl derivatives and the use thereof as integrin inhibitors
AU2002215911A1 (en) Oligonucleotides, agents containing these oligonucleotides, and the use thereof
HRP20020971A2 (en) 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-inhibitors
ZA200105277B (en) New amidinobenzylamine derivatives and their use as thrombin inhibitors.
ZA200100906B (en) Uracil compounds and use thereof.
IL162750A (en) Cryoprobe
ZA200003399B (en) Inhibitors.
ZA200003398B (en) Inhibitors.